Tag #Pharmaceutical Pricing

Showing 13 to 14 of 14 results

smh.com.au

🌐 85% Global Worthiness

Mar 19, 07:13

US Pharma Giants Seek Punitive Tariffs Against Australia Over Medicine Subsidies

American pharmaceutical giants are pushing for $18 billion in punitive tariffs against Australia over its Pharmaceutical Benefits Scheme (PBS), which they say cuts medicine prices and blocks American exports, with a decision expected next month.

US Pharma Giants Seek Punitive Tariffs Against Australia Over Medicine Subsidies

American pharmaceutical giants are pushing for $18 billion in punitive tariffs against Australia over its Pharmaceutical Benefits Scheme (PBS), which they say cuts medicine prices and blocks American exports, with a decision expected next month.

Progress

60% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate consequences of the US pharmaceutical industry's complaint against Australia's PBS, and what is its global significance?

American pharmaceutical companies are pushing for punitive tariffs on Australia due to its Pharmaceutical Benefits Scheme (PBS), which subsidizes medicines and reduces drug prices, impacting American exporters. This $18 billion scheme, according to the US industry, is "egregious and discriminatory", leading to billions in lost sales and undermining American competitiveness. The complaint was formally lodged with the US trade chief on March 11th.

elpais.com

🌐 85% Global Worthiness

Feb 6, 07:12

Wisconsin Man Dies After Inhaler Price Surge

A 22-year-old Wisconsin man, Cole Schmidtknecht, died from an asthma attack after his inhaler's price increased from $66 to $539 due to OptumRx, a UnitedHealth Group subsidiary, ending coverage; his parents are suing OptumRx, Walgreens, and Boots Alliance for negligence.

Wisconsin Man Dies After Inhaler Price Surge

A 22-year-old Wisconsin man, Cole Schmidtknecht, died from an asthma attack after his inhaler's price increased from $66 to $539 due to OptumRx, a UnitedHealth Group subsidiary, ending coverage; his parents are suing OptumRx, Walgreens, and Boots Alliance for negligence.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What were the direct causes of Cole Schmidtknecht's death, and what immediate changes are needed to prevent similar tragedies?

Cole Schmidtknecht, a 22-year-old from Wisconsin, died from an asthma attack after the price of his inhaler increased from a $66 copay to $539. His parents filed a lawsuit, alleging that OptumRx, a UnitedHealth Group subsidiary, stopped covering his medication, leaving him unable to afford it. This resulted in five days of untreated asthma symptoms before his death.

Showing 13 to 14 of 14 results